Stuart Rich - Precision medicine and pulmonary hypertension

A talk by Stuart Rich during the PVRI 11th Annual World Congress, January 2017, Miami, Florida

Additional keywords: precision, therapy, heterogeneity, 6mwd, clinical trial

About the author

Stuart Rich

Director, Bluhm Cardiovascular institute Pulmonary Vascular Disease Program.

Northwestern University

United States

"The PVRI has established itself as the only professional organization that is devoted exclusively towards addressing the field of pulmonary vascular diseases. To me, the greatest attribute of the PVRI has been its success with the annual scientific congress by bringing physicians from around the world, and from diverse areas of expertise, into a common arena to facilitate collaboration. The PVRI is responsible for contributing to progress more than people can appreciate."